Retraction: Identification of a novel ferroptosis inducer for gastric cancer treatment using drug repurposing strategy

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fmolb.2024.1491755

2024-09-11

Abstract:[This retracts the article DOI: 10.3389/fmolb.2022.860525.].

What problem does this paper attempt to address?

Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma

BioMed Research International

DOI: https://doi.org/10.1155/2022/9829634

2022-12-30

BioMed Research International

Abstract:BioMed Research International has retracted the article titled "Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma" [1] due to concerns that the peer review process has been compromised.

biotechnology & applied microbiology,medicine, research & experimental
Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fonc.2024.1383375

IF: 4.7

2024-02-22

Frontiers in Oncology

Abstract:This article is a retraction of: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma

oncology
Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fonc.2024.1383394

IF: 4.7

2024-02-21

Frontiers in Oncology

Abstract:[This retracts the article DOI: 10.3389/fonc.2022.1085305.].

oncology
Retraction: Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fonc.2024.1459966

2024-07-16

Abstract:[This retracts the article DOI: 10.3389/fonc.2021.636461.].
Retraction: NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial-mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fcell.2024.1491753

2024-09-11

Abstract:[This retracts the article DOI: 10.3389/fcell.2021.688949.].
miR-16-5p Regulates Ferroptosis by Targeting SLC7A11 in Adriamycin-Induced Ferroptosis in Cardiomyocytes [Retraction]

Yongquan Chen,Yecheng Deng,Linghua Chen,Ziyao Huang,Yi Yan,Zhaoqi Huang

DOI: https://doi.org/10.2147/jir.s463646

IF: 4.5

2024-02-01

Journal of Inflammation Research

Abstract:[This retracts the article DOI: 10.2147/JIR.S393646.].

immunology
Retraction: Disulfiram chelated with copper inhibits the growth of gastric cancer cells by modulating stress response and Wnt/β-catenin signaling

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fonc.2024.1475033

IF: 4.7

2024-08-30

Frontiers in Oncology

Abstract:This article is a retraction of: RETRACTED: Disulfiram Chelated With Copper Inhibits the Growth of Gastric Cancer Cells by Modulating Stress Response and Wnt/β-catenin Signaling

oncology
Retraction: Oncological effects and prognostic value of AMAP1 in gastric cancer

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fgene.2024.1491856

2024-09-11

Abstract:[This retracts the article DOI: 10.3389/fgene.2021.675100.].
Retracted: Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach

BioMed Research International

DOI: https://doi.org/10.1155/2024/9817451

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2022/6600403.].

biotechnology & applied microbiology,medicine, research & experimental
Retraction Note: STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

S-R Dong,X-L Ju,W-Z Yang

DOI: https://doi.org/10.26355/eurrev_202409_36716

Abstract:The article "STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells" by S.-R. Dong, X.-L. Ju, W.-Z. Yang, published in Eur Rev Med Pharmacol Sci 2019; 23 (19): 8360-8370 - PMID: 31646566 has been retracted by the Editor in Chief following the expression of concern published in May 2024, available at https://www.europeanreview.org/article/36273. Following concerns raised by third party and by readers on PubPeer (link: https://pubpeer.com/publications/2D2719EECB2A38AFB430AE920E0ADD), the Editor in Chief has started an investigation to assess the validity of the results as well as possible figure manipulation. The journal's investigation revealed duplications involving Figure 2F, Figure 3I, and Figure 4D with previously published articles (https://doi.org/10.18632/aging.102995 and https://doi.org/10.2147/DDDT.S151029). Additionally, a duplication was found between the GAPDH panels of MKN28 and AGS in Figure 3C. The authors have been informed about the journal's investigation but remained unresponsive and have not provided the study's raw data. Consequently, the Editor in Chief mistrusts the results presented and has decided to retract the article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/19147.
Retraction Note to: Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells

Mohammad Y Alfaifi,Ali A Shati,Serag Eldin I Elbehairi,Usama A Fahmy,Nabil A Alhakamy,Shadab Md

DOI: https://doi.org/10.1007/s13205-024-04007-5

IF: 2.893

3 Biotech

Abstract:[This retracts the article DOI: 10.1007/s13205-020-2077-x.].
A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]

Jingde Chen,Hong Jiang,Yin Wang,Yandong Li,Yong Gao

DOI: https://doi.org/10.2147/dddt.s398020

IF: 4.3188

2022-01-01

Drug Design Development and Therapy

Abstract:[This retracts the article DOI: 10.2147/DDDT.S81722.].
Retracted: Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach

BioMed Research International

DOI: https://doi.org/10.1155/2024/9878069

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2022/5908402.].

biotechnology & applied microbiology,medicine, research & experimental
RETRACTION: Retraction Note: Ethaselen Synergizes with Oxaliplatin in Tumor Growth Inhibition by Inducing ROS Production and Inhibiting TrxR1 Activity in Gastric Cancer (retraction of Vol 40, Art No 260, 2021)

Haiyong Zhang,Jing Wu,Jinqiu Yuan,Huafu Li,Yawei Zhang,Wang Wu,Wei Chen,Chunming Wang,Sijun Meng,Songyao Chen,Mingyu Huo,Yulong He,Changhua Zhang

DOI: https://doi.org/10.1186/s13046-022-02268-7

IF: 12.658

2022-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02052-z.
Retracted: FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer

BioMed Research International

DOI: https://doi.org/10.1155/2024/9837654

2024-01-09

BioMed Research International

Abstract:[This retracts the article DOI: 10.1155/2021/9986376.].

biotechnology & applied microbiology,medicine, research & experimental
[Retracted] SIRT6 Promotes Ferroptosis and Attenuates Glycolysis in Pancreatic Cancer Through Regulation of the NF‑κB Pathway.

Shuangxi Gong,Lixin Xiong,Zhen Luo,Qinghua Yin,Ming Huang,Yang Zhou,Jian Li

DOI: https://doi.org/10.3892/etm.2024.12751

IF: 2.7

2024-01-01

Experimental and Therapeutic Medicine

Abstract:[This retracts the article DOI: 10.3892/etm.2022.11430.].
Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fonc.2024.1383366

IF: 4.7

2024-02-19

Frontiers in Oncology

Abstract:[This retracts the article DOI: 10.3389/fonc.2023.1137913.].

oncology
Retracted: Influencing Factors of Gastrointestinal Function Recovery after Gastrointestinal Malignant Tumor

Journal of Healthcare Engineering

DOI: https://doi.org/10.1155/2023/9790312

2023-11-01

Journal of Healthcare Engineering

Abstract:[This retracts the article DOI: 10.1155/2021/6457688.].

health care sciences & services
Retracted: Intelligent Algorithm-Based CT Imaging for Evaluation of Efficacy of Docetaxel Combined with Fluorouracil on Patients with Gastric Cancer

Journal of Healthcare Engineering

DOI: https://doi.org/10.1155/2023/9756936

2023-10-11

Journal of Healthcare Engineering

Abstract:[This retracts the article DOI: 10.1155/2021/1040374.].

health care sciences & services
Retraction: In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis?

Frontiers Editorial Office

DOI: https://doi.org/10.3389/fendo.2024.1480220

2024-08-21

Abstract:[This retracts the article DOI: 10.3389/fendo.2022.745327.].

Retraction: Identification of a novel ferroptosis inducer for gastric cancer treatment using drug repurposing strategy

Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma

Retraction: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma

Retraction: A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer

Retraction: Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma

Retraction: NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial-mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3

miR-16-5p Regulates Ferroptosis by Targeting SLC7A11 in Adriamycin-Induced Ferroptosis in Cardiomyocytes [Retraction]

Retraction: Disulfiram chelated with copper inhibits the growth of gastric cancer cells by modulating stress response and Wnt/β-catenin signaling

Retraction: Oncological effects and prognostic value of AMAP1 in gastric cancer

Retracted: Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach

Retraction Note: STAT5A reprograms fatty acid metabolism and promotes tumorigenesis of gastric cancer cells

Retraction Note to: Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells

A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]

Retracted: Identification of Molecular Biomarkers and Key Pathways for Esophageal Carcinoma (EsC): A Bioinformatics Approach

RETRACTION: Retraction Note: Ethaselen Synergizes with Oxaliplatin in Tumor Growth Inhibition by Inducing ROS Production and Inhibiting TrxR1 Activity in Gastric Cancer (retraction of Vol 40, Art No 260, 2021)

Retracted: FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer

[Retracted] SIRT6 Promotes Ferroptosis and Attenuates Glycolysis in Pancreatic Cancer Through Regulation of the NF‑κB Pathway.

Retraction: Prognostic influence of PD-1/PD-L1 suppressors in combination with chemotherapeutic agents for non-small cell pulmonary carcinoma: system review and meta-analysis

Retracted: Influencing Factors of Gastrointestinal Function Recovery after Gastrointestinal Malignant Tumor

Retracted: Intelligent Algorithm-Based CT Imaging for Evaluation of Efficacy of Docetaxel Combined with Fluorouracil on Patients with Gastric Cancer

Retraction: In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis?